Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

694 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, Atzeni F, Behrens GM, Bijlsma JW, Böhm P, Constantinou CA, Garcia-Diaz S, Kapetanovic MC, Lauper K, Luís M, Morel J, Nagy G, Polverino E, van Rompay J, Sebastiani M, Strangfeld A, de Thurah A, Galloway J, Hyrich KL. Fragoulis GE, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2023 Jun;82(6):742-753. doi: 10.1136/ard-2022-223335. Epub 2022 Nov 3. Ann Rheum Dis. 2023. PMID: 36328476
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
Burmester GR, Mariette X, Montecucco C, Monteagudo-Sáez I, Malaise M, Tzioufas AG, Bijlsma JW, Unnebrink K, Kary S, Kupper H. Burmester GR, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2007 Jun;66(6):732-9. doi: 10.1136/ard.2006.066761. Epub 2007 Feb 28. Ann Rheum Dis. 2007. PMID: 17329305 Free PMC article. Clinical Trial.
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008.
Schoels M, Aletaha D, Smolen JS, Bijlsma JW, Burmester G, Breedveld FC, Cutolo M, Combe B, Dougados M, Emery P, Kalden J, Keystone EC, Kvien TK, Martin-Mola E, Montecucco C, De Wit M. Schoels M, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2010 Mar;69(3):575-8. doi: 10.1136/ard.2009.108472. Epub 2009 Apr 22. Ann Rheum Dis. 2010. PMID: 19389716 Free article.
Measurement invariance of the Illness Invalidation Inventory (3*I) across language, rheumatic disease and gender.
Kool MB, van de Schoot R, López-Chicheri García I, Mewes R, Da Silva JA, Vangronsveld K, Wismeijer AA, Lumley MA, van Middendorp H, Bijlsma JW, Crombez G, Rief W, Geenen R. Kool MB, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2014 Mar;73(3):551-6. doi: 10.1136/annrheumdis-2012-201807. Epub 2013 Feb 14. Ann Rheum Dis. 2014. PMID: 23413282
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis.
Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG, Doherty M, Geenen R, Hammond A, Kjeken I, Lohmander LS, Lund H, Mallen CD, Nava T, Oliver S, Pavelka K, Pitsillidou I, da Silva JA, de la Torre J, Zanoli G, Vliet Vlieland TP; European League Against Rheumatism (EULAR). Fernandes L, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2013 Jul;72(7):1125-35. doi: 10.1136/annrheumdis-2012-202745. Epub 2013 Apr 17. Ann Rheum Dis. 2013. PMID: 23595142 Free article.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.
Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D. Smolen JS, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25. Ann Rheum Dis. 2014. PMID: 24161836 Free PMC article.
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.
Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F. Strehl C, et al. Among authors: bijlsma jw. Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1. Ann Rheum Dis. 2016. PMID: 26933146 Review.
694 results